Victrex plc (VCT) Fair Value & Analysis
Basic Materials · GB · Market cap 564M GBX
Fair value as of: Jun 24, 2026
From 26 valuation models · updated 5 days ago
Share price −9.8% over the past month.
Price vs Fair Value (12 months)
12‑month range £5.48 – £7.56 · fair‑value band £4.07 – £6.78 · the £5.99 price screens above the £5.42 fair value. As of Jun 24, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
Victrex plc (VCT) currently trades at £5.99, while our model-based Fair Value estimate is £5.42 — implying the stock looks roughly 9.5% overvalued today. We read business quality at 95/100 (high quality), in the Basic Materials sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).
Over the trailing twelve months, Victrex plc generated revenue of £294M at a net margin of -6.7%. Revenue grew 0.8% year over year. It earns a return on equity of -9.4%. Net debt stands at £24.8M. Fundamentals as of Jun 24, 2026
Key figures & financial health
More key figures
Figures from reported company fundamentals (EODHD) · as of Jun 24, 2026. TTM = trailing twelve months.
About the company
Victrex plc, through its subsidiaries, engages in the manufacture and sale of polymer solutions worldwide. The company operates through two segments, Sustainable Solutions and Medical. It develops PEEK and PAEK based polymer solutions, and semi-finished and finished parts. The company also provides specialist solutions for medical device manufacturers; and sells thermoplastic polymers; sustainable solutions for energy and industrial, VAR, aerospace, automotive, and electronics markets, as well as engages in trading activities. It serves automotive, aerospace, energy and industrial, electronics, and medical markets. Victrex plc was incorporated in 1993 and is headquartered in Thornton-Cleveleys, the United Kingdom.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Victrex plc reported revenue of £296M in FY2025 versus £306M in FY2021, a compound −0.8%/yr. Reported net income was £27.8M in FY2025, compounding −21.5%/yr from FY2021.
Open the full interactive analysis →
Similar stocks
6 more Specialty Chemicals stocks, each showing price versus our Fair Value estimate (as of Jun 24, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Linde plc LIN | $509.16 | $159.69 | -69% |
| L'Air Liquide S.A AIQUY | $38.20 | $13.08 | -66% |
| Air Products and Chemicals, Inc A1PD34 | R$364.32 | R$50.60 | -86% |
| Intercontinental Exchange, Inc I1CE34 | R$334.47 | R$67.12 | -80% |
| Wanhua Chemical Group 600309 | ¥72.46 | ¥51.34 | -29% |
| Asian Paints Limited ASIANPAINT | ₹2,674 | ₹739.38 | -72% |
Explore undervalued stocks
More undervalued Basic Materials stocks →
Frequently asked questions
Is Victrex plc (VCT) undervalued?
What is the fair value of VCT?
What is the quality score of VCT?
What is the revenue of Victrex plc (VCT)?
What is the net profit margin of VCT?
Does Victrex plc pay a dividend?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.